Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy.
Manzano-Muñoz A, Yeste J, Ortega MA, Martín F, López A, Rosell J, Castro S, Serrano C, Samitier J, Ramón-Azcón J, Montero J.
Manzano-Muñoz A, et al. Among authors: yeste j.
NPJ Precis Oncol. 2022 Dec 1;6(1):90. doi: 10.1038/s41698-022-00333-0.
NPJ Precis Oncol. 2022.
PMID: 36456699
Free PMC article.